Receptor Antibody

Alibaba.com

Overview

Product sourcing insights & recommendations

ScienceDirect.com
Wikipedia
26 来源

I have synthesized the latest market insights and product trends for receptor antibodies. The market is rapidly evolving with a strong focus on Antibody-Drug Conjugates (ADCs) and AI-driven discovery, with the global antibody therapy market projected to reach $1.01 trillion by 2035.

Key findings include:

  • Oncology Dominance: The HER2 receptor remains the leading target, particularly in the surging ADC segment where Pfizer's $43B acquisition of Seagen has set a major industry benchmark.
  • Neurology Breakthroughs: A shift from symptomatic care to disease-modifying treatments for Alzheimer's (e.g., Lecanemab and Donanemab) is creating new diagnostic and therapeutic infrastructures.
  • Supply Trends: Primary research antibodies for targets like ETBR, GLP-1R, and Estrogen Receptor Alpha dominate the research segment, alongside a high demand for diagnostic ELISA kits (e.g., for AChR antibodies).

The attached report provides a detailed analysis of market sizes, CAGR forecasts (2024–2030), and current B2B product offerings.

Based on the market trends, I can provide more details on:

Deep Dive · Full Report

Full Market Report

1 document · Live-fetched from source